Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 3
2013 5
2014 2
2015 3
2016 1
2017 3
2018 5
2019 4
2020 9
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers.
Sabari JK, Leonardi GC, Shu CA, Umeton R, Montecalvo J, Ni A, Chen R, Dienstag J, Mrad C, Bergagnini I, Lai WV, Offin M, Arbour KC, Plodkowski AJ, Halpenny DF, Paik PK, Li BT, Riely GJ, Kris MG, Rudin CM, Sholl LM, Nishino M, Hellmann MD, Rekhtman N, Awad MM, Drilon A. Sabari JK, et al. Among authors: umeton r. Ann Oncol. 2018 Oct 1;29(10):2085-2091. doi: 10.1093/annonc/mdy334. Ann Oncol. 2018. PMID: 30165371 Free PMC article.
Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14-Mutant NSCLC.
Recondo G, Bahcall M, Spurr LF, Che J, Ricciuti B, Leonardi GC, Lo YC, Li YY, Lamberti G, Nguyen T, Milan MSD, Venkatraman D, Umeton R, Paweletz CP, Albayrak A, Cherniack AD, Price KS, Fairclough SR, Nishino M, Sholl LM, Oxnard GR, Jänne PA, Awad MM. Recondo G, et al. Among authors: umeton r. Clin Cancer Res. 2020 Jun 1;26(11):2615-2625. doi: 10.1158/1078-0432.CCR-19-3608. Epub 2020 Feb 7. Clin Cancer Res. 2020. PMID: 32034073 Free article.
Impact of DNA Damage Response and Repair (DDR) Gene Mutations on Efficacy of PD-(L)1 Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer.
Ricciuti B, Recondo G, Spurr LF, Li YY, Lamberti G, Venkatraman D, Umeton R, Cherniack AD, Nishino M, Sholl LM, Shapiro GI, Awad MM, Cheng ML. Ricciuti B, et al. Among authors: umeton r. Clin Cancer Res. 2020 Aug 1;26(15):4135-4142. doi: 10.1158/1078-0432.CCR-19-3529. Epub 2020 Apr 24. Clin Cancer Res. 2020. PMID: 32332016 Free article.
Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis.
Buscarinu MC, Romano S, Mechelli R, Pizzolato Umeton R, Ferraldeschi M, Fornasiero A, Reniè R, Cerasoli B, Morena E, Romano C, Loizzo ND, Umeton R, Salvetti M, Ristori G. Buscarinu MC, et al. Among authors: umeton r. Neurotherapeutics. 2018 Jan;15(1):68-74. doi: 10.1007/s13311-017-0582-3. Neurotherapeutics. 2018. PMID: 29119385 Free PMC article. Review.
Genome-Wide Multiple Sclerosis Association Data and Coagulation.
La Starza S, Ferraldeschi M, Buscarinu MC, Romano S, Fornasiero A, Mechelli R, Umeton R, Ristori G, Salvetti M. La Starza S, et al. Among authors: umeton r. Front Neurol. 2019 Feb 14;10:95. doi: 10.3389/fneur.2019.00095. eCollection 2019. Front Neurol. 2019. PMID: 30837932 Free PMC article. Review.
SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation.
Keyhanian K, Umeton RP, Mohit B, Davoudi V, Hajighasemi F, Ghasemi M. Keyhanian K, et al. Among authors: umeton rp. J Neuroimmunol. 2020 Nov 7;350:577436. doi: 10.1016/j.jneuroim.2020.577436. Online ahead of print. J Neuroimmunol. 2020. PMID: 33212316 Free PMC article. Review.
SARS-CoV-2 and Acute Cerebrovascular Events: An Overview.
Ghasemi M, Umeton RP, Keyhanian K, Mohit B, Rahimian N, Eshaghhosseiny N, Davoudi V. Ghasemi M, et al. Among authors: umeton rp. J Clin Med. 2021 Jul 29;10(15):3349. doi: 10.3390/jcm10153349. J Clin Med. 2021. PMID: 34362133 Free PMC article. Review.
IFN-β and multiple sclerosis: from etiology to therapy and back.
Annibali V, Mechelli R, Romano S, Buscarinu MC, Fornasiero A, Umeton R, Ricigliano VA, Orzi F, Coccia EM, Salvetti M, Ristori G. Annibali V, et al. Among authors: umeton r. Cytokine Growth Factor Rev. 2015 Apr;26(2):221-8. doi: 10.1016/j.cytogfr.2014.10.010. Epub 2014 Oct 31. Cytokine Growth Factor Rev. 2015. PMID: 25466632 Review.
36 results